Redmile Group’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

Redmile Group’s Portfolio AYLA Stock Details AYLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-341,030	Closed	-$372K	–	77
2022 Q2	$372K	Sell	341,030 -108,701	-24%	-$248K	0.01%	71
2022 Q1	$1.79M	Sell	449,731 -218,085	-33%	-$1.13M	0.06%	67
2021 Q4	$5.68M	Hold	667,816	–	–	0.13%	64
2021 Q3	$7.57M	Hold	667,816	–	–	0.13%	68
2021 Q2	$6.8M	Hold	667,816	–	–	0.1%	76
2021 Q1	$7.29M	Hold	667,816	–	–	0.1%	78
2020 Q4	$7.61M	Buy	667,816 +1,150	+0.2%	+$13.3K	0.09%	74
2020 Q3	$7.85M	Hold	666,666	–	–	0.14%	72
2020 Q2	$6.69M	Buy	+666,666	New	+$9.26M	0.12%	71

Other funds holding AYLA

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Redmile Group's AYLA Position: Q3 2022 in Review

Redmile Group sold out of Ayala Pharmaceuticals, Inc. Common Stock (AYLA) in Q3 2022, closing a stake of 341,030 shares — an estimated $372K sold.

Redmile Group first reported a position in AYLA in Q2 2020 and held it in 9 quarters. The position peaked at $7.85M in Q3 2020. 14 funds tracked by Wall St. Rank hold AYLA as of Q3 2022.

Redmile Group reported no remaining Ayala Pharmaceuticals, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Redmile Group sold 341,030 Ayala Pharmaceuticals, Inc. Common Stock shares in Q3 2022, an estimated $372K.
Redmile Group first reported a position in Ayala Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 9 quarters.
Redmile Group's Ayala Pharmaceuticals, Inc. Common Stock position peaked at $7.85M in Q3 2020.
14 funds tracked by Wall St. Rank held Ayala Pharmaceuticals, Inc. Common Stock as of Q3 2022.

Based on Redmile Group's 13F filing for Q3 2022, filed 14 Nov 2022.